Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: June 27, 2025

  • Open
    55.34
  • High
    55.90
  • Low
    54.71
  • Close
    55.69
  • Volume
    1,547,510

Financial ratios

Dec 31, 2024